Abstract
During the R-->T transition in the tetrameric pig kidney fructose-1,6-bisphosphatase (Fru-1,6-P2ase, EC 3.1.3.11) a major change in the quaternary structure of the enzyme occurs that is induced by the binding of the allosteric inhibitor AMP (Ke HM, Liang JY, Zhang Y, Lipscomb WN, 1991, Biochemistry 30:4412-4420). The change in quaternary structure involving the rotation of the upper dimer by 17 degrees relative to the lower dimer is coupled to a series of structural changes on the secondary and tertiary levels. The structural data indicate that Lys-42 is involved in a complex set of intersubunit interactions across the dimer-dimer interface with residues of the 190's loop, a loop located at the pivot of the allosteric rotation. In order to test the function of Lys-42, we have replaced it with alanine using site-specific mutagenesis. The kcat and K(m) values for Lys-42-->Ala Fru-1,6-P2ase were 11 s-1 and 3.3 microM, respectively, resulting in a mutant enzyme that was slightly less efficient catalytically than the normal pig kidney enzyme. Although the Lys-42-->Ala Fru-1,6-P2ase was similar kinetically in terms of K(m) and kcat, the response to inhibition by AMP was significantly different than that of the normal pig kidney enzyme. Not only was AMP inhibition no longer cooperative, but also it occurred in two stages, corresponding to high- and low-affinity binding sites. Saturation of the high-affinity sites only reduced the activity by 30%, compared to 100% for the wild-type enzyme. In order to determine in what structural state the enzyme was after saturation of the high-affinity sites, the Lys-42-->Ala enzyme was crystallized in the presence of Mn2+, fructose-6-phosphate (Fru-6-P), and 100 microM AMP and the data collected to 2.3 A resolution. The X-ray structure showed the T state with AMP binding with full occupancy to the four regulatory sites and the inhibitor Fru-6-P bound at the active sites. The results reported here suggest that, in the normal pig kidney enzyme, the interactions between Lys-42 and residues of the 190's loop, are important for propagation of AMP cooperativity to the adjacent subunit across the dimer-dimer interface as opposed to the monomer-monomer interface, and suggest that AMP cooperativity is necessary for full allosteric inhibition by AMP.
Full Text
The Full Text of this article is available as a PDF (2.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Grazi E., Magri E., Traniello S. Active subunits of rabbit liver fructose diphosphatase. Biochem Biophys Res Commun. 1973 Oct 15;54(4):1321–1325. doi: 10.1016/0006-291x(73)91131-5. [DOI] [PubMed] [Google Scholar]
- Ke H. M., Liang J. Y., Zhang Y. P., Lipscomb W. N. Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form). Biochemistry. 1991 May 7;30(18):4412–4420. doi: 10.1021/bi00232a007. [DOI] [PubMed] [Google Scholar]
- Ke H. M., Zhang Y. P., Lipscomb W. N. Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5243–5247. doi: 10.1073/pnas.87.14.5243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367–382. doi: 10.1016/0076-6879(87)54085-x. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lu G., Williams M. K., Giroux E. L., Kantrowitz E. R. Fructose-1,6-bisphosphatase: arginine-22 is involved in stabilization of the T allosteric state. Biochemistry. 1995 Oct 17;34(41):13272–13277. doi: 10.1021/bi00041a002. [DOI] [PubMed] [Google Scholar]
- Marcus F., Edelstein I., Reardon I., Heinrikson R. L. Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7161–7165. doi: 10.1073/pnas.79.23.7161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nimmo H. G., Tipton K. F. The effect of pH on the kinetics of beef-liver fructose bisphosphatase. Eur J Biochem. 1975 Oct 15;58(2):567–574. doi: 10.1111/j.1432-1033.1975.tb02407.x. [DOI] [PubMed] [Google Scholar]
- Pilkis S. J., El-Maghrabi M. R., Pilkis J., Claus T. Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate. J Biol Chem. 1981 Apr 25;256(8):3619–3622. [PubMed] [Google Scholar]
- Riou J. P., Claus T. H., Flockhart D. A., Corbin J. D., Pilkis S. J. In vivo and in vitro phosphorylation of rat liver fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4615–4619. doi: 10.1073/pnas.74.10.4615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Villeret V., Huang S., Zhang Y., Lipscomb W. N. Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. Biochemistry. 1995 Apr 4;34(13):4307–4315. doi: 10.1021/bi00013a020. [DOI] [PubMed] [Google Scholar]
- Williams M. K., Kantrowitz E. R. Isolation and sequence analysis of the cDNA for pig kidney fructose 1,6-bisphosphatase. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3080–3082. doi: 10.1073/pnas.89.7.3080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xue Y., Huang S., Liang J. Y., Zhang Y., Lipscomb W. N. Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12482–12486. doi: 10.1073/pnas.91.26.12482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y., Liang J. Y., Huang S., Ke H., Lipscomb W. N. Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. Biochemistry. 1993 Feb 23;32(7):1844–1857. doi: 10.1021/bi00058a019. [DOI] [PubMed] [Google Scholar]